Studying microcirculation to treat sepsis early
Part of Infections clinical trials.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You came to the Emergency Room with a suspected infection that started less than 6 hours ago (fever of 101°F or more, plus a high NEWS2 score).
- You are covered by social security (health insurance).
- Your systolic blood pressure is above 100 mmHg (not too low).
- You have not already received a 500 mL fluid test for this infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at a new program to improve how doctors and nurses treat sepsis (a severe infection that can cause organ failure) in the emergency department. It aims to see if the program helps start the right treatments faster.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study looks at how well blood flows to the skin of patients with sepsis in the ICU. It aims to see if this can help predict recovery and guide care.
This study looks at a special blood flow monitor (perfusion index) to see if it can help doctors decide when to give blood pressure raising medicines in patients with serious infections. It might help doctors better treat sepsis and septic shock.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.